Literature DB >> 33160010

Comparing neural correlates of conditioned inhibition between children with and without anxiety disorders - A preliminary study.

Anita Harrewijn1, Elizabeth R Kitt2, Rany Abend2, Chika Matsumoto2, Paola Odriozola3, Anderson M Winkler2, Ellen Leibenluft2, Daniel S Pine2, Dylan G Gee3.   

Abstract

Cognitive-behavioral therapy (CBT), a first-line treatment for pediatric anxiety disorders, is based on principles of threat learning and extinction. However, CBT does not work sufficiently for up to 40% of clinically anxious youth. The neural and behavioral correlates of conditioned inhibition might provide promising targets for attempts to improve CBT response. During conditioned inhibition, threat and safety cues appear together, forming a safety compound. Here, we test whether this safety compound elicits a reduced fear response compared to pairing the threat cue with a novel cue (novel compound). The current pilot study compares behavioral, physiological, and neural correlates of conditioned inhibition between children with (n = 17, Mage = 13.09, SDage = 3.05) and without (n = 18, Mage = 14.49, SDage = 2.38) anxiety disorders. Behavioral and physiological measures did not differ between children with and without anxiety disorders during fear acquisition. During testing, children with anxiety disorders showed overall higher skin conductance response and expected to hear the aversive sound following the novel compound more often than children without anxiety disorders. Children with anxiety disorders showed more activity in the right ventromedial prefrontal cortex (vmPFC) to the safety versus novel compound. Children without anxiety disorders showed the opposite pattern - more right vmPFC activity to the novel versus safety compound (F(1,31) = 5.40, p = 0.03). No group differences manifested within the amygdala, dorsal anterior cingulate cortex, or hippocampus. These pilot findings suggest a feasible approach for examining conditioned inhibition in pediatric anxiety disorders. If replicated in larger samples, findings may implicate perturbed conditioned inhibition in pediatric anxiety disorders and provide targets for CBT. Published by Elsevier B.V.

Entities:  

Keywords:  Anxiety; Conditioned inhibition; Development; Exposure; Fear acquisition

Mesh:

Year:  2020        PMID: 33160010      PMCID: PMC7855938          DOI: 10.1016/j.bbr.2020.112994

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  69 in total

1.  A cognitive-behavioral model of anxiety in social phobia.

Authors:  R M Rapee; R G Heimberg
Journal:  Behav Res Ther       Date:  1997-08

Review 2.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

3.  Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data.

Authors:  J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-07       Impact factor: 8.829

4.  Fear responses to safety cues in anxious adolescents: Preliminary evidence for atypical age-associated trajectories of functional neural circuits.

Authors:  Anneke D M Haddad; Amy Bilderbeck; Anthony C James; Jennifer Y F Lau
Journal:  J Psychiatr Res       Date:  2015-05-21       Impact factor: 4.791

Review 5.  Fear extinction as a model for translational neuroscience: ten years of progress.

Authors:  Mohammed R Milad; Gregory J Quirk
Journal:  Annu Rev Psychol       Date:  2012       Impact factor: 24.137

6.  Neural signatures of human fear conditioning: an updated and extended meta-analysis of fMRI studies.

Authors:  M A Fullana; B J Harrison; C Soriano-Mas; B Vervliet; N Cardoner; A Àvila-Parcet; J Radua
Journal:  Mol Psychiatry       Date:  2015-06-30       Impact factor: 15.992

Review 7.  State-of-the-art and future directions for extinction as a translational model for fear and anxiety.

Authors:  Michelle G Craske; Dirk Hermans; Bram Vervliet
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-03-19       Impact factor: 6.237

8.  Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A).

Authors:  Kathleen Ries Merikangas; Jian-Ping He; Marcy Burstein; Sonja A Swanson; Shelli Avenevoli; Lihong Cui; Corina Benjet; Katholiki Georgiades; Joel Swendsen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-07-31       Impact factor: 8.829

9.  Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia.

Authors:  Amit Etkin; Tor D Wager
Journal:  Am J Psychiatry       Date:  2007-10       Impact factor: 18.112

10.  Differential effects of prior stress on conditioned inhibition of fear and fear extinction.

Authors:  Ellen P Woon; Tara A Seibert; Phillip J Urbanczyk; Ka H Ng; Susan Sangha
Journal:  Behav Brain Res       Date:  2019-12-28       Impact factor: 3.332

View more
  2 in total

1.  Structure and function differences in the prelimbic cortex to basolateral amygdala circuit mediate trait vulnerability in a novel model of acute social defeat stress in male mice.

Authors:  Yael S Grossman; Clementine Fillinger; Alessia Manganaro; George Voren; Rachel Waldman; Tiffany Zou; William G Janssen; Paul J Kenny; Dani Dumitriu
Journal:  Neuropsychopharmacology       Date:  2021-11-19       Impact factor: 8.294

Review 2.  Safety learning during development: Implications for development of psychopathology.

Authors:  Lana Ruvolo Grasser; Tanja Jovanovic
Journal:  Behav Brain Res       Date:  2021-04-18       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.